Long-Term (6 Months) Cross-Over Comparison of Calcium Acetate with Calcium Carbonate as Phosphate Binder

Nephron ◽  
1993 ◽  
Vol 63 (3) ◽  
pp. 258-262 ◽  
Author(s):  
F. Ben Hamida ◽  
I. El Esper ◽  
M. Compagnon ◽  
Ph. Morinière ◽  
A. Fournier
Keyword(s):  
Calcium Carbonate ◽  
Phosphate Binder ◽  
Calcium Acetate

Long-term comparison of a calcium-free phosphate binder and calcium carbonate - phosphorus metabolism and cardiovascular calcification

2004 ◽  
Vol 62 (08) ◽  
pp. 104-115 ◽  
Author(s):  
J. Braun ◽  
H.-G. Asmus ◽  
H. Holzer ◽  
R. Brunkhorst ◽  
R. Krause ◽  
...  
Keyword(s):  
Calcium Carbonate ◽  
Phosphate Binder ◽  
Phosphorus Metabolism

Calcium acetate versus calcium carbonate as oral phosphate binder in pediatric and adolescent hemodialysis patients

1996 ◽  
Vol 10 (5) ◽  
pp. 625-630 ◽  
Author(s):  
Michael Wallot ◽  
Klaus-Eugen Bonzel ◽  
Andreas Winter ◽  
Birgit Geörger ◽  
Bernhard Letten ◽  
...  
Keyword(s):  
Calcium Carbonate ◽  
Phosphate Binder ◽  
Hemodialysis Patients ◽  
Calcium Acetate

Efficacy and Safety of Long-Term Treatment With Calcium Carbonate as a Phosphate Binder

1988 ◽  
Vol 12 (6) ◽  
pp. 487-491 ◽  
Author(s):  
Fabio Malberti ◽  
Maurizio Surian ◽  
Francesco Poggio ◽  
Claudio Minoia ◽  
Alessandro Salvadeo
Keyword(s):  
Calcium Carbonate ◽  
Phosphate Binder ◽  
Term Treatment ◽  
Efficacy And Safety ◽  
Long Term Treatment

scholarly journals Plasma Zinc Decreases in Hemodialysis Patients Treated with Calcium Carbonate as the Phosphate Binder

Nephron ◽  
1989 ◽  
Vol 53 (4) ◽  
pp. 384-385 ◽  
Author(s):  
Paolo Gilli ◽  
Dino Docci ◽  
Leopoldo Baldrati ◽  
Fausto Turci
Keyword(s):  
Calcium Carbonate ◽  
Phosphate Binder ◽  
Hemodialysis Patients ◽  
Plasma Zinc

scholarly journals COMPARATIVE STUDY BETWEEN THE EFFECT OF HISTAMINE RECEPTOR ANTAGONISTS OF TYPE II (FAMOTIDINE) AND PROTON PUMP INHIBITORS (OMEPRAZOLE) ON THE EFFICACY OF CALCIUM CARBONATE AS PHOSPHATE BINDER IN HAEMODIALYSIS PATIENT

2017 ◽  
Vol 9 (8) ◽  
pp. 10
Author(s):  
Hossam Aboelyazeed ◽  
Sahar El-haggar ◽  
Kamal Okasha
Keyword(s):  
Calcium Carbonate ◽  
Serum Calcium ◽  
Phosphate Binder ◽  
Renal Dialysis ◽  
University Hospital ◽  
Control Group ◽  
Group Iii ◽  
Group I ◽  
Group Ii ◽  
Pre Treatment

Objective: The purpose of this study was to compare the effect of famotidine versus omeprazole on the efficacy of calcium carbonate as a phosphate binder in the hemodialysis patient.Methods: From February 2014 to June 2014 a total number of 64 patients of both sexes were recruited from the department of renal dialysis, Tanta University Hospital, Egypt. Patients categorized into 3 groups. Group I (control group) consisted of 20 Patients (10) females and (10) males take calcium carbonate (caco3) (2.5–4 g/d) only, Group II consisted of 21 Patients (13) females and (8) males take the same dose of caco3 with famotidine 10 mg/d and Group III consisted of 23 Patients (8) females and (15) male take the same dose caco3 with omeprazole 20 mg/d.Results: All data are expressed as the mean±SD. Group II showed a significant increase (p<0.05) in serum phosphorus at 3rd mo with significant decreased (p<0.05) in serum calcium comparing with pre-treatment. Group III showed no significant change (p>0.05) in serum calcium, phosphorus and parathyroid hormone (PTH) comparing with pre-treatment. Both groups (II and III) showed a significant decrease in alkaline phosphatase (ALP) (p<0.05).Conclusion: Co-administration of famotidine with calcium carbonate aggravates hyperphosphatemia and this may increase the incidence of complications. The efficacy of calcium carbonate as a phosphate binder was not affected by co-administration of omeprazole.

scholarly journals Properties of Cement Mortar Using Limestone Sludge Powder Modified with Recycled Acetic Acid

2019 ◽  
Vol 11 (3) ◽  
pp. 879
Author(s):  
Hwa-Sung Ryu ◽  
Deuck-Mo Kim ◽  
Sang-Heon Shin ◽  
Wan-Ki Kim ◽  
Seung-Min Lim ◽  
...  
Keyword(s):  
Acetic Acid ◽  
Cement Mortar ◽  
Surface Characteristics ◽  
Calcium Acetate ◽  
Raw Material ◽  
Limestone Powder ◽  
Low Carbon ◽  
Pore Filling ◽  
Initial Strength

One of the various methods of manufacturing low-carbon cement is substituting limestone powder as a raw material or admixture. Limestone sludge powder (LSSP) has the same composition as that of limestone powder. The surface characteristics of LSSP powder modified with recycled acetic acid (RAA) and the characteristics of cement using this modified LSSP as a substitute were investigated in this study. The surface of LSSP modified with RAA was converted into calcium acetate and had a large grain size. When conventional LSSP was used as a substitute for cement, the initial strength increased owing to improved pore filling; however, the strength after 28 days of aging was lower than that of non-substituted cement. In the case of modified LSSP being replaced with cement at up to 10% of the cement weight, however, the calcium acetate on its surface increased the amount of hydration products in the cement, thereby increasing both the initial and the long-term strength.

Calcium Carbonate as a Phosphate Binder: Is There a Need to Adjust Peritoneal Dialysate Calcium Concentrations for Patients Using CaCO3?

1989 ◽  
Vol 9 (4) ◽  
pp. 325-328 ◽  
Author(s):  
Leo Martis ◽  
Kenneth D. Serkes ◽  
Karl D. Nolph
Keyword(s):  
Peritoneal Dialysis ◽  
Calcium Carbonate ◽  
Phosphate Binder ◽  
Dialysis Patients ◽  
Oral Calcium ◽  
Dialysis Solution ◽  
Effective Use ◽  
Dialysis Solutions ◽  
Dialysate Calcium ◽  
Peritoneal Dialysis Solutions

The widespread use of calcium carbonate as a phosphate binder is limited by its tendency to develop hypercalcemia in some patients using effective dosages needed to control hyperphosphatemia. Most common continuous ambulatory peritoneal dialysis (CAPD) regimens using dialysis solutions containing 3.5 mEqlL of calcium result in net absorption of calcium from the dialysis solution and, hence limit the amount of oral calcium that can be administered. Peritoneal dialysis solutions with reduced calcium levels are needed for effective use of CaCO3 to control hyperphosphatemia in some dialysis patients.

Sign in / Sign up

Export Citation Format

Share Document